DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,446,286 | -2.0% | 311,242 | +7.0% | 0.22% | -1.8% |
| Q2 2023 | $69,836,727 | +16.7% | 290,847 | +22.5% | 0.23% | -5.8% |
| Q1 2023 | $59,855,719 | -2.6% | 237,485 | +2.6% | 0.24% | -12.7% |
| Q4 2022 | $61,430,157 | +6.2% | 231,371 | +3.5% | 0.28% | -6.1% |
| Q3 2022 | $57,828,000 | +1.9% | 223,653 | 0.0% | 0.29% | +11.8% |
| Q2 2022 | $56,740,000 | -12.8% | 223,653 | +0.8% | 0.26% | +3.1% |
| Q1 2022 | $65,053,000 | -8.3% | 221,778 | +2.8% | 0.25% | -3.8% |
| Q4 2021 | $70,977,000 | +3.9% | 215,699 | -3.9% | 0.26% | -4.7% |
| Q3 2021 | $68,286,000 | +10.6% | 224,436 | -2.5% | 0.28% | +9.9% |
| Q2 2021 | $61,762,000 | +16.3% | 230,170 | -2.4% | 0.25% | +3.7% |
| Q1 2021 | $53,086,000 | +4.4% | 235,726 | +3.0% | 0.24% | -9.0% |
| Q4 2020 | $50,866,000 | -42.0% | 228,918 | -44.9% | 0.27% | -49.7% |
| Q3 2020 | $87,711,000 | +22.2% | 415,732 | -0.2% | 0.53% | +6.0% |
| Q2 2020 | $71,790,000 | +12.8% | 416,586 | -7.8% | 0.50% | -2.5% |
| Q1 2020 | $63,656,000 | -6.0% | 452,022 | +2.0% | 0.51% | +9.6% |
| Q4 2019 | $67,739,000 | +6.3% | 443,171 | +0.4% | 0.47% | -2.7% |
| Q3 2019 | $63,699,000 | +1.7% | 441,267 | +0.7% | 0.48% | -18.6% |
| Q2 2019 | $62,619,000 | +9.3% | 438,220 | +0.9% | 0.59% | +31.3% |
| Q1 2019 | $57,315,000 | +42.6% | 434,204 | +10.0% | 0.45% | +28.1% |
| Q4 2018 | $40,194,000 | +51.1% | 394,718 | +46.5% | 0.35% | +31.3% |
| Q2 2018 | $26,596,000 | +34.4% | 269,501 | +37.5% | 0.27% | -17.0% |
| Q2 2016 | $19,793,000 | +13838.7% | 195,977 | -98.5% | 0.32% | +59.1% |
| Q1 2016 | $142,000 | -99.3% | 13,500,759 | +6377.1% | 0.20% | -32.6% |
| Q4 2015 | $19,461,000 | +10.4% | 208,438 | +0.8% | 0.30% | +6.0% |
| Q3 2015 | $17,623,000 | -89.2% | 206,823 | +9.7% | 0.28% | -7.5% |
| Q4 2014 | $162,596,000 | +1057.2% | 188,528 | +1.7% | 0.31% | -13.0% |
| Q3 2014 | $14,051,000 | +6.7% | 185,401 | +4.3% | 0.35% | +16.5% |
| Q2 2014 | $13,169,000 | -2.3% | 177,791 | -1.0% | 0.30% | -3.2% |
| Q1 2014 | $13,483,000 | +22.3% | 179,605 | +26.6% | 0.31% | +11.8% |
| Q4 2013 | $11,022,000 | +5.7% | 141,887 | -2.0% | 0.28% | +0.4% |
| Q3 2013 | $10,426,000 | +14.2% | 144,711 | +0.9% | 0.28% | +4.9% |
| Q2 2013 | $9,131,000 | – | 143,442 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |